Transcriptional hallmarks of HCC include limitless replicative potential resulting from reactivation of TERT, evasion of apoptosis, and activation of VEGFA, PDGFA, or ANGPT2, resulting in neoangiogenesis. The gene discussed is TERT; the disease is hepatocellular carcinoma.